Expertise in
19
conditions

Dr. Irene L. Wapnir

General Surgery
Interventional Radiology In San Jose
2589 Samaritan Dr, 
San Jose, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
Expertise in
19
conditions
Interventional Radiology In San Jose
2589 Samaritan Dr, 
San Jose, CA 

Overview

Irene Wapnir is a General Surgeon practicing medicine in San Jose, California.

Dr. Wapnir is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, Mastectomy, and Lymphadenectomy.

She is actively involved in clinical research, co-authoring 90 peer reviewed articles and participating in 11 clinical trials.

Specialties

General Surgery

Licenses

Surgery in CA

Hospital Affiliations

Stanford Health Care

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 2 Less Insurance Carriers -

Locations

Interventional Radiology In San Jose
2589 Samaritan Dr, San Jose, CA 95124
Other Locations
Office
300 Pasteur Dr, Stanford, CA 94305

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Randomized Phase II Study Comparing Surgical Excision Versus Neoadjuvant Radiotherapy Followed by Delayed Surgical Excision of Ductal Carcinoma In Situ (NORDIS)
A Randomized Phase II Study Comparing Surgical Excision Versus Neoadjuvant Radiotherapy Followed by Delayed Surgical Excision of Ductal Carcinoma In Situ (NORDIS)
Enrollment Status: Recruiting
Publish Date: March 12, 2026
Intervention Type: Radiation, Procedure
Study Phase: Not Applicable
A Randomized, Double-Blind, Phase III Trial of Taxane/Trastuzumab/Pertuzumab With Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
A Randomized, Double-Blind, Phase III Trial of Taxane/Trastuzumab/Pertuzumab With Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
Enrollment Status: Terminated
Publish Date: May 29, 2026
Intervention Type: Other, Procedure, Biological, Drug
Study Drugs: Atezolizumab, Paclitaxel, Pertuzumab, Trastuzumab
Study Phase: Phase 3
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: May 06, 2026
Intervention Type: Drug, Other
Study Drugs: Carboplatin, Cyclophosphamide, Doxorubicin Hydrochloride, Paclitaxel
Study Phase: Phase 3
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: February 10, 2026
Intervention Type: Drug, Other
Study Drugs: Anastrozole, Everolimus, Exemestane, Goserelin Acetate, Letrozole, Leuprolide Acetate, Tamoxifen Citrate
Study Phase: Phase 3
A Study Evaluating the Pregnancy Outcomes and Safety of Interrupting Endocrine Therapy for Young Women With Endocrine Responsive Breast Cancer Who Desire Pregnancy
A Study Evaluating the Pregnancy Outcomes and Safety of Interrupting Endocrine Therapy for Young Women With Endocrine Responsive Breast Cancer Who Desire Pregnancy
Enrollment Status: Active_not_recruiting
Publish Date: February 09, 2026
Intervention Type: Other
Study Phase: Not Applicable
Feasibility Study to Evaluate Performance of the LUM Imaging System for Intraoperative Detection of Residual Tumor in Breast Cancer Patients Receiving and Not Receiving Neoadjuvant Therapy
Feasibility Study to Evaluate Performance of the LUM Imaging System for Intraoperative Detection of Residual Tumor in Breast Cancer Patients Receiving and Not Receiving Neoadjuvant Therapy
Enrollment Status: Terminated
Publish Date: January 15, 2025
Intervention Type: Drug, Device
Study Drug: LUM Imaging System used During Surgery
Study Phase: Phase 2
Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival and Frozen Human Tissue Samples
Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival and Frozen Human Tissue Samples
Enrollment Status: Completed
Publish Date: August 03, 2023
A Pilot Study to Assess the Utility of Indocyanine Green™ (IC-GREEN™) SPY Imaging in the Mapping of Arm Draining Lymphatics and Nodes During Sentinel Node Resection With or Without Axillary Dissection in Breast Cancer
A Pilot Study to Assess the Utility of Indocyanine Green™ (IC-GREEN™) SPY Imaging in the Mapping of Arm Draining Lymphatics and Nodes During Sentinel Node Resection With or Without Axillary Dissection in Breast Cancer
Enrollment Status: Completed
Publish Date: December 11, 2017
Intervention Type: Drug, Device
Study Phase: Phase 2
A Phase 1 Trial of AVB-620 in Women With Primary, Non-Recurrent Breast Cancer Undergoing Surgery
A Phase 1 Trial of AVB-620 in Women With Primary, Non-Recurrent Breast Cancer Undergoing Surgery
Enrollment Status: Completed
Publish Date: March 22, 2017
Intervention Type: Drug
Study Phase: Phase 1
A Feasibility Study of Radiofrequency Identification (RFID) Localization of Breast Lesions
A Feasibility Study of Radiofrequency Identification (RFID) Localization of Breast Lesions
Enrollment Status: Withdrawn
Publish Date: February 02, 2017
Intervention Type: Procedure, Other
Study Phase: Not Applicable
View 9 Less Clinical Trials

90 Total Publications

Erratum: Survival Outcomes in Breast Cancer Patients With Use of Vaginal Estrogen Therapy: A SEER Analysis.
Erratum: Survival Outcomes in Breast Cancer Patients With Use of Vaginal Estrogen Therapy: A SEER Analysis.
Journal: JCO oncology practice
Published: July 30, 2026
Similar Doctors
Expertise in
67
conditions
Dr. George A. Poultsides
General Surgery
Expertise in
67
conditions
Dr. George A. Poultsides
General Surgery
Referral may be required

Stanford University

875 Blake Wilbur Dr, 
Palo Alto, CA 
 (17.7 miles away)
650-498-6000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

George Poultsides is a General Surgeon practicing medicine in Palo Alto, California. Dr. Poultsides is highly rated in 67 conditions, according to our data. His clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Neuroendocrine Tumor, Gallbladder Cancer, Hepatectomy, and Pancreatectomy.

Expertise in
30
conditions
Dr. Electron Kebebew
General Surgery
Expertise in
30
conditions
Dr. Electron Kebebew
General Surgery
Referral may be required

Stanford Hospital And Clinics

965 High St, 
Palo Alto, CA 
 (17.2 miles away)
650-723-4000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Electron Kebebew is a General Surgeon practicing medicine in Palo Alto, California. Dr. Kebebew is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Pheochromocytoma, Adrenal Cancer, Anaplastic Thyroid Cancer, Parathyroidectomy, and Thyroidectomy.

Expertise in
15
conditions
Dr. Brooke H. Gurland
General Surgery
Expertise in
15
conditions
Dr. Brooke H. Gurland
General Surgery
Referral may be required
Before you request

Stanford University Medical Center

450 Broadway St, 
Redwood City,, CA 
 (21.2 miles away)
650-723-4000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Brooke Gurland is a General Surgeon practicing medicine in Redwood City,, California. Dr. Gurland is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Rectal Prolapse, Bowel Incontinence, Levator Syndrome, Pelvic Laparoscopy, and Sacral Nerve Stimulation. Dr. Gurland is currently accepting new patients.

Frequently Asked Questions about Dr. Irene L. Wapnir

How do I make an appointment with Dr. Irene L. Wapnir?

You can book an appointment with Dr. Irene L. Wapnir by calling their office at 408-426-4900. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Irene L. Wapnir a top-rated expert for Mastectomy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Irene L. Wapnir is classified as an Elite expert for Mastectomy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Irene L. Wapnir specialize in?

While Dr. Irene L. Wapnir is a General Surgery, they have specific expertise in Mastectomy, Breast Cancer, and Angiosarcoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within General Surgery.

Does Dr. Irene L. Wapnir participate in research or clinical trials?

Yes. Dr. Irene L. Wapnir has published 90 articles and abstracts on conditions like Mastectomy. You can view a list of Dr. Irene L. Wapnir's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Irene L. Wapnir accept my insurance?

Dr. Irene L. Wapnir accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 408-426-4900 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wapnir's expertise for a condition
ConditionClose
View All 13 Advanced Conditions
View All 23 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile